Adastra Holdings Ltd · CSE:XTRX
Adastra — Investor Presentation (January 2023)
16 slides from Adastra's investor presentation, January 2023
Slide 1: Cannabis Through Art and Science
CANNABIS THROUGH ART AND SCIENCE INVESTOR PRESENTATION | JANUARY 2023 CSE: XTRX | FRA: D2EP
Slide 2: Disclaimer
DISCLAIMER Investors and pros pective investors shoul d rely onl y on the information contained in the disclosure filings (the “Filings”) of Adastra Holdings Ltd. (the “Company”). This presentation is qualified in its entirety by reference to, and must be read in conjuncti on with, the information c
Slide 3: The Art, The Science, The Expertise
THE ART THE SCIENCE THE EXPERTISE At Adastra we’ve created the new standard in cannabis extracts. Our deep understanding of our customers’ needs allows us to deliver trusted, quality products to the end consumer. It takes a touch of art, a lot of science, and plenty of industry expertise. CSE: XTRX
Slide 4: Investment Highlights
INVESTMENT HIGHLIGHTS LEVERAGING CANADA'S STRONGEST CANNABIS BRANDS Adastra owns 100% of the popular legacy Phyto Extractions brand and developed successful in-house brand Endgame Extracts in 2022. Phyto Extractions' portfolio includes; distillate and full spectrum vaporizer cartridges, shatter and
Slide 5: Key Product Offerings
KEY PRODUCT OFFERINGS CRYO ETHANOL HYDROCARBON FULL SPECTRUM DRIED SUPER/SUB FLOWER CRITICAL CO2 Distillate Vape Extract Products: Live Resin, Pre-Rolls, Infused Pre-Rolls, Capsules, Tinctures, Shatter, Live Extract Cartridges, Tinctures Shatter, THCa Diamonds, Large format cannabis flower, Full Spe
Slide 6: Experienced Leadership Team
EXPERIENCED LEADERSHIP TEAM With a background firmly rooted Smoke is a highly accomplished CEO, entrepreneur, leader, board member in medicine, cannabis production and philanthropist with leadership across the consumer products, and entrepreneurship, Michael beverage, cannabis, hospitality, health &
Slide 7: A Platform for Accelerated Growth in Canada
A PLATFORM FOR ACCELERATED GROWTH IN CANADA Trusted global leaders in pharma-quality, development and manufacturing of cannabis API, and derivative products EXTRACT Our extraction methodologies and industry-leading equipment are designed to meet your product development requirements. ANALYZE Our co-
Slide 8: Adastra Labs
ADASTRA LABS EXTRACTION Adastra Labs is a Health Canada licensed Standard Processor, cannabis product formulator and co-manufacturer. Our 13,500 sq. ft facility is located in Langley, BC, Canada. In 2021, Adastra received its sales license to sell products directly to provincial distributors. The hy
Slide 9: Adastra Analytics
ADASTRA ANALYTICS IN-HOUSE TESTING LAB Licensed by Health Canada in 2019, Adastra Analytics is Adastra's co-located testing laboratory. Adastra conducts in-process cannabinoid potency testing, enhancing process efficiency and product quality assurance. It also offers QA/ QC and compliance services f
Slide 10: Owns 100% of Two Top-Performing Canadian Concentrates Brands
OWNS 100% of TWO TOP-PERFORMING CANADIAN CONCENTRATES BRANDS + AWARD-WINNING EXTRACTS Proudly Canadian and fiercely passionate about cannabis concentrates, Phyto Extractions is a legacy purveyor of award-winning extracts. Evolving from our legacy roots, we carefully consider hardware, formulation in
Slide 11: PerceiveMD
“ PERCEIVEMD ONE OF BRITISH COLUMBIA’S LEADING MEDICAL Through acquiring CANNABIS AND FORWARD-THINKING THERAPY CLINICS COMPASSIONATE CARE PerceiveMD and its PerceiveMD is a multidisciplinary team-based, patient-focused centre extensive team of providing free, comprehensive assessments for medical ca
Slide 12: Growing Product Portfolio and Availability
GROWING PRODUCT PORTFOLIO AND AVAILABILITY Expanding Distribution with Provincial Wholesalers GROWTH DRIVERS Available to • • Introduction of new products, into desired categories Retail & market penetration ~1,400+ • New channels retailers across Canada • Optimize in-store visibility and augmented
Slide 13: Building Momentum
• Achieved gross profit of approximately $1.9 million during the year ended December 31, 2021 - an increase of Q4 2021 147%. BUILDING MOMENTUM • Supply and Purchase agreement with Sitka Weed Works. • Launched Endgame Extracts brand in BC, with a 100% sell through of initial SKU launch within 48 hour
Slide 14: YTD 2022 Financial Metrics
YTD 2022 FINANCIAL METRICS YTD 2022 YTD 2021 % Change Revenue $9,142,062 $3,639,012 151% Cost of Sales ($5,584,825) ($2,379,083) 135% Gross Profit $3,557,237 $1,259.929 336% Gross Margin 38.9% 34.6% 4.3% Operating $4,999,311 $2,043,174 145% Expenses Net Loss ($1,106,715) ($1,081,266) 48% Net Loss Pe
Slide 15: Capital Structure
CAPITAL STRUCTURE CSE: XTRX $0.39 $0.39–$1.10 $21.8M 1% (1) TICKER SHARE PRICE 52-WEEK RANGE MARKET CAP INSIDERS Shares Outstanding Total Shares (as of June 30, 2022) Common Shares 55,970,547 Options 3,665,000 Warrants 2,043,911 Total Shares Outstanding (Fully Diluted) 61,679,458 Long-Term Debt - (1
Slide 16: Get In Touch With Us
Get In Touch With Us MICHAEL FORBES, CEO & DIRECTOR michael@adastraholdings.ca +1 (250) 882-3784
Adastra Holdings — Investor Presentation (January 2023) on 6ix